|
Product Details:
Payment & Shipping Terms:
|
| CAS: | 144060-53-7 | Product Name: | Febuxostat |
|---|---|---|---|
| Type: | Pharmaceutical Intermediate | Appearance: | White Powder |
| Usage: | Antigout Drug | Alias: | Febuxostat |
| Assay: | 99%min | Key Words: | Febuxostat |
| High Light: | pharmaceutical grade raw materials,intermediates in pharmaceuticals |
||
99% min Febuxostat Intermediate Febuxostat API CAS 144060-53-7 Febuxostat Impurity
Details
Product Description
Febuxostat for Prevention and Treatment of Hyperuricemia and Gout 144060-53-7
Synonyms: 2-[3-Cyano-4-isobutoxyphenyl]-4-methylthiazole-5-carboxylic acid; 2-[3-Cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid
Molecular Formula: C16H16N2O3S
Molecular Weight: 316.37
CAS No: 144060-53-7
Melting Point: 238-239 ° C
Boiling Point: 536.6 ° C at 760 mmHg
Appearance: White crystall powder.
Assay:No less than 99%
Usage:Used for the prevention and treatment of hyperuricemia and gout.
Specification:
Product name |
Lansoprazole |
| CAS NO. | 103577-45-3 |
| Synonyms | Lansoprazole;17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione |
| Category | Pharmaceutical Raw Materials,Active Pharmaceutical Ingredients,Bulk Drugs,Fine Chemicals. |
| Standard | purity:>99% |
| Appearance | Lansoprazole powder |
| Shelf life | 2 years |
| Usage | Lansoprazole is a proton-pump inhibitor (PPI) which inhibits the stomach's production of gastric acids.Lansoprazole is manufactured by a number of companies worldwide under several brand names. Lansoprazole is a proton-pump inhibitor (PPI) in the same pharmacologic class as omeprazole.Lansoprazole has been marketed for many years and is one of several PPIs available.Lansoprazole is a racemate 1:1-mixture of the enantiomers dexlansoprazole and levolansoprazole. |
Storage |
Lansoprazole should be stored in a well-closed container at low temperature, keep away from moisture, heat and light. |
Description
Febuxostat is a new generation xanthine oxidase inhibitor developed by Tejin Co. (Japan,) used clinically for for long-term treatment of hyperuicemia (gout,) a new and highly effective non-purine selective inhibitor of xanthine oxidase. It is not recommended for gout patients without hyperuricemia.
COA
| Item | Specification |
| Appearance | White to off-white crystalline powder |
| Identification | HPLC/IR |
| Related Substances | Total impurities: NMT 0.1% Maximum single impurity: NMT 0.3% |
| Loss on drying (Dry it at 105ºC in an electric air blowing dryer till a constant weight) | NMT 1.0% |
| Residue on Ignition | NMT 0.1% |
| Heavy metal | NMT 20ppm |
| Chlorides | NMT 0.04% |
| Assay (on dried basis) | 98.0% ~ 102.0% |
99% min Febuxostat Intermediate Febuxostat API CAS 144060-53-7 Febuxostat Impurity
Contact Person: bruce
Tel: +8618874586545
